Cytokinetics Total Non-Operating Income/Expense 2010-2024 | CYTK

Cytokinetics total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.052B, a 67.5% increase year-over-year.

  • Cytokinetics annual total non-operating income/expense for 2023 was $-0.03B, a 53.61% decline from 2022.
  • Cytokinetics annual total non-operating income/expense for 2022 was $-0.065B, a 123.28% increase from 2021.
  • Cytokinetics annual total non-operating income/expense for 2021 was $-0.029B, a 13.03% decline from 2020.

Cytokinetics Total Non-Operating Income/Expense 2010-2024 | CYTK

  • Cytokinetics annual total non-operating income/expense for 2023 was $-0.03B, a 53.61% decline from 2022.
  • Cytokinetics annual total non-operating income/expense for 2022 was $-0.065B, a 123.28% increase from 2021.
  • Cytokinetics annual total non-operating income/expense for 2021 was $-0.029B, a 13.03% decline from 2020.